TECH BIO-TECHNE CORP
2026Q1 · CUSIP 09073M104 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
576
Δ holders QoQ
-3
Breadth percentile
Top 73%
Whale holders
224
Δ whales
+5
Inst. holding value
$9.1B
New positions
72
Closed positions
75
Price momentum (1Q)
-23.9%
Put / Call
12/9
Breadth history (34 quarters)
Past Lit Events & Aftermath 12 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 17% | -0.5% | -20.1% |
| 2024Q2 | Top 14% | -2.5% | -11.4% |
| 2024Q1 | Top 11% | -10.4% | -19.2% |
| 2021Q3 | Top 2% | -18.3% | -28.7% |
| 2021Q2 | Top 3% | +5.7% | -13.2% |
| 2021Q1 | Top 12% | +23.3% | +30.4% |
| 2020Q3 | Top 9% | +31.2% | +31.5% |
| 2020Q2 | Top 17% | +15.4% | +55.3% |
Options Sentiment
Put holders
12
QoQ: 0
Call holders
9
QoQ: -5
See methodology →
Fundamentals
PE (TTM)
103.2
EPS (TTM)
$0.69
EPS YoY
-16.9%
Revenue (TTM)
$1.2B
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)